• 6 results in Exploration of Drug Science
    Sort by
    Open Access
    Mini Review
    Mini-review on the antimicrobial potential of actinobacteria associated with seagrasses
    The search for novel therapeutic agents to combat the crisis of antimicrobial resistance has spanned from terrestrial to unique, marine environments. Currently, most of the drugs available for usage [...] Read more.
    Galana Siro, Atanas Pipite
    Published: February 29, 2024 Explor Drug Sci. 2024;2:117–125
    DOI: https://doi.org/10.37349/eds.2024.00038
    This article belongs to the special issue Exploring Potential Drugs from Natural Products
    Times Cited: 0
    Open Access
    Influenza A virus hemagglutinin: from classical fusion inhibitors to proteolysis targeting chimera-based strategies in antiviral drug discovery
    The influenza virus glycoprotein hemagglutinin (HA) participates in critical steps of the attachment of viral particles to the host cell membrane receptor and membrane fusion. Due to its crucial inv [...] Read more.
    Francisco Javier Hermoso-Pinilla ... Francisco Javier Luque
    Published: February 29, 2024 Explor Drug Sci. 2024;2:85–116
    DOI: https://doi.org/10.37349/eds.2024.00037
    Times Cited: 0
    Open Access
    Seaweed: a sustainable solution for greening drug manufacturing in the pursuit of sustainable healthcare
    The environmental impact of drug manufacturing raises concerns about sustainability in healthcare. To address this, exploring alternative approaches to drug production is crucial. This review focuse [...] Read more.
    Leonel Pereira, João Cotas
    Published: February 27, 2024 Explor Drug Sci. 2024;2:50–84
    DOI: https://doi.org/10.37349/eds.2024.00036
    This article belongs to the special issue Greening Drug Manufacturing for a Sustainable Healthcare
    Open Access
    Effect of the size of nucleic acid delivery systems on their fate in cancer treatment
    Nucleic acid therapeutics are emerging as a promising class of medicines, offering unique therapeutic options for cancer at the gene level. However, the druggability of nucleic acid therapeutics is  [...] Read more.
    Mengyun Ye ... Dandan Zhu
    Published: February 01, 2024 Explor Drug Sci. 2024;2:38–49
    DOI: https://doi.org/10.37349/eds.2024.00035
    This article belongs to the special issue Emerging Nanomedicine Technologies for Enhanced Cancer Theranostics
    Times Cited: 0
    Open Access
    Revisiting 310-helices: biological relevance, mimetics and applications
    310-Helices represent the third most abundant secondary structure proteins. Although understandably overshadowed by α-helices for decades, the 310-helix structure is slowly regaining certain releva [...] Read more.
    Diego Núñez-Villanueva
    Published: February 01, 2024 Explor Drug Sci. 2024;2:6–37
    DOI: https://doi.org/10.37349/eds.2024.00034
    This article belongs to the special issue Mimicking Nature: Biomimetics as Tools for Diagnosis and Therapeutics
    Times Cited: 0
    Open Access
    Case Report
    Histological diagnosis of primary biliary cholangitis in one patient without cholestasis alterations: a case report that escaped guidelines
    Primary biliary cholangitis (PBC) is an autoimmune cholangiopathy that affects mainly women and, if untreated, can evolve into biliary cirrhosis. Its prevalence varies worldwide, depending on race,  [...] Read more.
    Matteo Biagi ... Pietro Andreone
    Published: January 22, 2024 Explor Drug Sci. 2024;2:1–5
    DOI: https://doi.org/10.37349/eds.2024.00033
    This article belongs to the special issue Innovative Therapeutics in Hepato-Gastroenterology
    Times Cited: 0